Acquisition of common shares of Bradmer Pharmaceuticals Inc.

    GRAND CAYMAN, Cayman Islands, Nov. 8 /CNW/ - Highbridge International LLC
("Highbridge") announced that it acquired 687,400 common shares of Bradmer
Pharmaceuticals Inc. ("Bradmer") through an open market purchase on the
Toronto Stock Exchange on November 7, 2007, which represent approximately 5.1%
of Bradmer's outstanding common shares. Following the acquisition of the
common shares acquired on November 7, 2007, Highbridge holds an aggregate of
1,985,900 common shares, representing approximately 14.6% of the outstanding
common shares of Bradmer. Highbridge also holds warrants to purchase 536,750
common shares, which, if Highbridge were to exercise in full, would result in
it holding 2,522,650 common shares, representing 17.9% of the outstanding
common shares.
    The acquisition of the common shares of Bradmer was made for investment
purposes only and not with the current intention of acquiring control of
Bradmer. Highbridge may, subject to market conditions and in accordance with
applicable securities laws, make additional investments in or dispositions of
securities of Bradmer, including additional purchases of common shares of

    Further information (including a copy of the report to be filed with
Canadian securities regulators in connection with this acquisition) can be
obtained by contacting:

    Highbridge International LLC
    c/o Harmonic Fund Services
    The Cayman Corporate Centre, 4th Floor
    27 Hospital Road
    Grand Cayman, Cayman Islands, British West Indies

    D. Brooke Harlow
    (212) 287-6843

For further information:

For further information: D. Brooke Harlow, (212) 287-6843

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890